• Evonik broke ground on a biotechnology expansion at its Fermas site in Slovenská Ľupča, Slovakia, as part of an EUR 80 million program.
• Project adds downstream fermentation technology to expand development and manufacturing capacity for complex pharmaceutical intermediates within its drug substance CDMO business.
• Completion is expected in early 2028, with about 50 new jobs planned at the site.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evonik Industries AG published the original content used to generate this news brief on September 14, 2026, and is solely responsible for the information contained therein.